Stem Cell Umbilical Cord Blood (UCB) Market Analysis & Forecast, (2015-2019)

1
Global Stem Cell Umbilical Cord Blood (UCB)
Market , 2015-2019
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global and China Trends, Company
Profiles, Demand, Insights, Analysis, Research,
Report, Opportunities, Segmentation and Forecast,
2013 - 2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview
UCB is the blood that remains in the placenta and
the attached umbilical cord after childbirth. UCB
contains stem cells that are unique, smart, and
are capable of treating several life-threatening
diseases. They are used in the treatment of
hematopoietic and genetic disorders. The
placental blood can produce 10 times more
quantity of stem cells compared to the umbilical
cord, which can in turn be used for the treatment
of an adult patient. The cord blood that is
collected during the childbirth is stored and
cryopreserved. The storage of the cord blood can
be done at private cord blood banks or public
cord blood banks. This preserved blood can be
used for the transplantation, and treatment of
diseases at the later stages of life. Technavios
analysts forecast the global stem cell UCB market
to grow at a CAGR of 30.36 over the period
2014-2019. To view more details visit
http//www.researchbeam.com/global-stem-cell-umbil
ical-cord-blood-ucb-2015-2019-market The report
covers the present scenario and the growth
prospects of the global stem cell UCB market for
the period 2015-2019. To calculate the market
size, the report considers revenue generated from
the banking and utilization of UCB stem cells for
the treatment of various disorders, such as
cancers, blood disorders, metabolic disorders,
immune diseases, and others. Technavios report,
Global Stem Cell UCB Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, APAC, and EMEA it also
covers the landscape of the global stem cell UCB
market and its growth prospects in the coming
years.
3


Report Overview
Key Regions Americas APAC EMEA Key
Vendors Caladrius Biosciences Celgene
Mesoblast Pluristem Therapeutics Other
Prominent Vendors Athersys CHA Bio and
Diostech Cytori Therapeutics Nuo
Therapeutics Ocata Therapeutics Opexa
Therapeutics Osiris Therapeutics Teva
Pharmaceuticals United Therapeutics
4


Report Overview
Key Questions Answered in this Report What will
the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? To Enquire about report
visit http//www.researchbeam.com/global-stem-ce
ll-umbilical-cord-blood-ucb-2015-2019-market
5


Table Of Contents

• Executive Summary
• 02. List of Abbreviations
• 03. Scope of the Report
• 03.1 Market Overview
• 04. Market Research Methodology
• 04.1 Market Research Process
• 04.2 Research Methodology
• 05. Introduction
• 06. Process of Collection, Processing and Storage
  of Cord Blood Cells
• 06.1 Donor Evaluation
• 06.2 Collection Methods
• 06.3 Processing and Storage Methods
• 06.4 Sample Retention and Length of Storage

6



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/global-stem-cell-umbil
ical-cord-blood-ucb-2015-2019-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com